U.S. — Revenue
Geographic · RevenueEli Lilly U.S. — Revenue increased by 14.0% to $12.88B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 42.6%, from $9.03B to $12.88B. Over 4 years (FY 2021 to FY 2025), U.S. — Revenue shows an upward trend with a 26.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates growing market demand, successful product launches, or effective pricing strategies, while a decrease may signal competitive pressure, patent expirations, or supply chain constraints.
Detailed definition
This metric measures the total gross revenue generated from the sale of pharmaceutical products within the United States...
Peer comparison
Large-cap pharmaceutical companies typically disclose regional revenue splits, allowing for direct comparison of domestic market share and growth rates against industry competitors.
lly_segment_us_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.70B | $3.99B | $5.18B | $5.17B | $3.93B | $4.42B | $4.66B | $4.44B | $5.53B | $5.37B | $6.46B | $5.69B | $7.84B | $7.81B | $9.03B | $8.49B | $10.81B | $11.30B | $12.88B |
| QoQ Change | — | +7.7% | +29.7% | -0.0% | -24.0% | +12.4% | +5.3% | -4.8% | +24.7% | -3.0% | +20.3% | -11.8% | +37.6% | -0.3% | +15.6% | -6.0% | +27.4% | +4.5% | +14.0% |
| YoY Change | — | — | — | — | +6.2% | +10.8% | -10.0% | -14.3% | +40.6% | +21.4% | +38.6% | +28.4% | +41.6% | +45.6% | +39.9% | +49.1% | +38.0% | +44.6% | +42.6% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Eli Lilly's u.s. — revenue?
- Eli Lilly (LLY) reported u.s. — revenue of $12.88B in Q4 2025.
- How has Eli Lilly's u.s. — revenue changed year-over-year?
- Eli Lilly's u.s. — revenue increased by 42.6% year-over-year, from $9.03B to $12.88B.
- What is the long-term trend for Eli Lilly's u.s. — revenue?
- Over 4 years (2021 to 2025), Eli Lilly's u.s. — revenue has grown at a 26.8% compound annual growth rate (CAGR), from $16.81B to $43.48B.
- What does u.s. — revenue mean?
- The total amount of money earned from selling products in the United States.